⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNY News
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Global Perfusion Systems Market to Register Incremental Growth at a CAGR of ~5% by 2034 | DelveInsight
globenewswire.com
MDT
LIVN
BSX
THC
AMGN
AZN
PFE
JNJ
MRNA
BMY
GILD
REGN
TEVA
CL
PG
KO
PEP
DIS
NVDA
GOOG
AMZN
MSFT
AAPL
TSLA
META
CRM
ADBE
NFLX
INTC
AMD
QCOM
CMCSA
T
VZ
IBM
ORCL
CSCO
ACN
HON
GE
BA
CAT
XOM
CVX
JPM
BAC
WFC
C
GS
MS
AXP
V
MA
HD
MCD
SBUX
COST
WMT
TGT
LOW
CVS
UNH
CI
ETSY
ROKU
PYPL
MELI
EBAY
BABA
JD
PDD
NTES
BIDU
TM
SONY
SAP
AIR
ASML
BNTX
NVO
BP
FCX
BHP
RIO
VALE
NKE
LULU
UA
CROX
NOC
GD
LMT
RTX
AVGO
AMAT
LRCX
MU
NXPI
MRVL
SNPS
CDNS
VRTX
BIIB
LLY
ABBV
MRK
CHTR
CMG
SIRI
GEHC
GSK
SNY
MREO
AAFA Highlights New Resources for Nasal Polyps in Recognition of Global CRSwNP Awareness Day
globenewswire.com
AMGN
AZN
SNY
REGN
Press Release: Q1 2026: double-digit sales and business EPS growth
globenewswire.com
SNY
Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria
globenewswire.com
REGN
SNY
Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)
globenewswire.com
REGN
SNY
Breakthrough T1D Celebrates Approval of Tzield for Use in Young Children to Delay the Onset of Insulin-Dependent Type 1 Diabetes
prnewswire.com
SNY
AI in Drug Discovery Market to Reach USD 160.49 Billion, Rising at a 23.22% CAGR by 2035
globenewswire.com
AMZN
JNJ
NVS
SNY
AZN
PFE
GSK
MRNA
BMY
LLY
MRK
ABBV
Paratus Appoints Alicia Secor as President and Chief Executive Officer; Expands Leadership Team to Support Next Phase of Growth
globenewswire.com
ZNTL
CRBU
AZN
PFE
TLRY
CATX
SYPR
SGBX
TMDX
LMT
TKO
TAK
SNY
EXAS
Press Release: Sanofi's Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children
globenewswire.com
SNY
Press Release: Sanofi provides update on the regulatory submission for Sarclisa subcutaneous in the US
globenewswire.com
SNY